80 likes | 199 Vues
The increase in people labeled with major medical conditions has surged due to altered definitions of diseases. In the last decade, 75% of the adult U.S. population is now identified as having at least one of four significant medical issues. This dramatic shift raises questions about the influence of drug companies on medical experts who define diseases and develop treatment guidelines. Understanding the intersection of medical definitions and pharmaceutical interests is crucial for patients and healthcare professionals alike.
E N D
Suddenly Sick http://seattletimes.nwsource.com/news/health/suddenlysick/suddenlysick.pdf
Change a number, create a patient The number of people with at least one of four major medical conditions has increased dramatically in the past decade because of changes in the definitions of disease. "The new definitions ultimately label 75 percent of the adult U.S. population as diseased," according to calculations by two Dartmouth Medical School researchers.
Creating Medical Experts Drug companies are often behind the experts' rise to prominence Here's how it works: Members of medical panels that define diseases and writetreatment guidelines are frequently considered among the top experts in their fields.